AWH Aspira Women's Health, Inc.: רווח נקי למניה בארבעת הרבעונים האחרונים

Stable demand for ovarian cancer tests is driven by strict US medical protocols. On GURU.Markets, the trailing twelve-month EPS chart demonstrates profit dynamics, where -277.40 serves as the final level marker. A centralized laboratory reduces costs, increasing the overall profitability of Aspira Women's Health (AWH). The humanitarian status of biomedicine minimizes geopolitical threats, ensuring business resilience.
aspirawh.com - פילוחים אנליטיים ומדדי מפתח (AWH)

Demand for Aspira Women's Health (AWH) oncology tests is inelastic, rendering the business resilient to inflationary shocks. The EPS YoY TTM shift metric quantifies this stability by comparing the rolling trailing twelve-month earnings per share against the same period last year. This chart's price action reveals hidden drawdowns between quarterly reports, filtering out market noise. The metric's growth confirms the effective scaling of this defensive medical service. Investors must track this trend to assess operating margins.